22834-22102 - Pharmacology of Drugs of Abuse

On Demand Instructions

Tuesday, September 12, 2023, 10:19 AM - Saturday, September 12, 2026, 11:19 AM


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Credit For Attending An AMA PRA Category 1 Event (1.00 hours)

A set of asynchronous learning modules in Addiction Medicine covering the most recent and relevant information regarding the prevention, diagnosis and treatment of substance use disorders. Intended to increase provider knowledge and comfort in caring for patients with a variety of substance use disorders. Includes content expected by Georgia Drug Enforcement Administration (DEA) for license renewal.

1. Understanding the role of addiction as a chronic disease
2. Understanding the neurobiology of addiction
3. Learning the options for popular screening tools
4. Understanding the symptoms and management of substance intoxication
5. Understanding the symptoms and management of withdrawal from substances

Cancellation Policy

The Medical College of Georgia reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
The Medical College of Georgia is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Mitigation of Relevant Financial Relationships

The Medical College of Georgia at Augusta University adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.